iShares U.S. Pharmaceuticals ETF is an exchange-traded fund that seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index, providing investors with exposure to U.S. pharmaceutical companies. The fund holds a diversified portfolio of established pharmaceutical firms engaged in drug discovery, development, manufacturing, and distribution across therapeutic areas. As a cap-weighted index fund, it emphasizes larger pharmaceutical companies while maintaining broad sector coverage. The ETF offers quarterly dividend distributions and charges a low expense ratio, making it an accessible vehicle for investors seeking targeted exposure to the pharmaceutical industry. The fund serves both individual and institutional investors looking to gain equity exposure to the U.S. pharmaceutical sector without holding individual pharmaceutical stocks.
United States
Hold-rated iShares US Pharmaceuticals ETF: fair valuation, concentrated holdings, weak technicals, and seasonal headwinds. Learn more about the IHE ETF here.
IHE's concentrated pharma holdings delivered 50% returns over one year, while RSPH's equal-weight healthcare approach generated 29%. Risk profiles differ sharply too.
IHE's concentrated pharma focus delivered 50% gains versus IYH's 27.4%, though the broader healthcare fund offers more diversification and $3.9B in assets.
IHE delivered 53.2% returns over one year with lower volatility and a 0.37% expense ratio, while PBE's quantitative biotech strategy carries higher risk.
VanEck's concentrated 25-stock biotech play offers higher volatility, while iShares' broader pharma exposure delivered a 1.4% dividend yield and lower drawdown risk.
Investors talking about IHE also mention
| # | Name | Attention |
|---|---|---|
| 1 | Invesco Pharmaceuticals ETFPJP | 0%new |
| 2 | SPDR S&P Pharmaceuticals ETFXPH | 0%new |
| 3 | VanEck Pharmaceutical ETFPPH | 0%new |
| 4 | Health Care Select Sector SPDR FundXLV | 0.01%-0.01 |
| 5 | Freedom 100 Emerging Markets ETFFRDM | 0%0 |
| 6 | iShares Biotechnology ETFIBB | 0.01%0 |
| 7 | SPDR S&P Biotech ETFXBI | 0.42%+0.08 |
| 8 | Invesco S&P MidCap Momentum ETFXMMO | 0%0 |
| 9 | Vanguard Health Care ETFVHT | 0.13%+0.12 |
| 10 | Eli Lilly and CompanyLLY | 0.16%+0.07 |
What share of all ETF conversation is about IHE?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% 0 | 0% 0 | 0% +0 |
Of the messages about IHE that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | — | 87.62% -1.36 | ||
| Bearish | — | — | — | 12.38% +1.36 |
Of the messages about IHE that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Technical Analysis | — | — | — | 86.02% | ||
| Macro | — | — | — | 13.98% |
Of the messages about IHE, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | — | — | 33.18% | ||
| Newcomers | — | — | — | 66.82% |